PlusVitech initiates clinical trial to treat incurable lung cancer patients
The Spanish biotechnology and medicine company PlusVitech has launched a Phase II clinical trial to treat patients with incurable lung cancer with the treatments available to date. The PVT-REMOVE treatment that PlusVitech proposes in this clinical trial, repositioning an oral drug that, according to the company’s previous results, successfully eliminates cancer because it takes control…